Conolidine’s analgesic outcomes stem from its interaction with non-opioid pain pathways. As opposed to opioids, which bind to µ-opioid receptors in the central nervous program, conolidine modulates alternate molecular targets. A Science Improvements analyze found that conolidine interacts While using the atypical chemokine receptor ACKR3/CXCR7, … Read More